Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Assets (2021 - 2025)

Xeris Biopharma Holdings' Return on Assets history spans 5 years, with the latest figure at 0.0% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 17.0% year-over-year to 0.0%, compared with a TTM value of 0.0% through Dec 2025, up 17.0%, and an annual FY2025 reading of 0.0%, up 17.0% over the prior year.
  • Return on Assets for Q4 2025 was 0.0% at Xeris Biopharma Holdings, up from 0.04% in the prior quarter.
  • The five-year high for Return on Assets was 0.0% in Q4 2025, with the low at 0.56% in Q4 2021.
  • Average Return on Assets over 5 years is 0.23%, with a median of 0.19% recorded in 2024.
  • Year-over-year, Return on Assets grew 27bps in 2022 and then decreased -1bps in 2024.
  • Tracing XERS's Return on Assets over 5 years: stood at 0.56% in 2021, then soared by 48bps to 0.29% in 2022, then soared by 35bps to 0.19% in 2023, then increased by 11bps to 0.17% in 2024, then soared by 101bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for XERS's Return on Assets are 0.0% (Q4 2025), 0.04% (Q3 2025), and 0.1% (Q2 2025).